Nemes Rush Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.98K | Buy |
102
+6
| +6% | +$469 | ﹤0.01% | 494 |
|
|
2025
Q1 | $6.96K | Sell |
96
-179
| -65% | -$13K | ﹤0.01% | 500 |
|
|
2024
Q4 | $20.4K | Sell |
275
-8,924
| -97% | -$661K | ﹤0.01% | 392 |
|
|
2024
Q3 | $879K | Sell |
9,199
-1,770
| -16% | -$169K | 0.13% | 91 |
|
|
2024
Q2 | $1.01M | Buy |
10,969
+1,651
| +18% | +$153K | 0.14% | 85 |
|
|
2024
Q1 | $890K | Sell |
9,318
-45,919
| -83% | -$4.39M | 0.13% | 92 |
|
|
2023
Q4 | $4.21M | Buy |
55,237
+2,995
| +6% | +$228K | 0.68% | 44 |
|
|
2023
Q3 | $3.62M | Buy |
52,242
+4,301
| +9% | +$298K | 0.66% | 45 |
|
|
2023
Q2 | $4.52M | Buy |
+47,941
| New | +$4.52M | 0.8% | 42 |
|